Jeffrey M. Leiden

Vertex Pharmaceuticals

Chairman, President & CEO

Overview

Jeffrey M. Leiden made an average of $18.4M in compensation at Vertex Pharmaceuticals from 2011 to 2017.

Annual data

2017

In 2017, Jeffrey M. Leiden earned a total compensation of $17.2M as Chairman, President & CEO at Vertex Pharmaceuticals.

Ranking194 out of 13,165
Percentile98.5%

Jeffrey M. Leiden's 2017 compensation ranked 194th out of 13,165 executive pay records tracked by us this year.

Jeffrey M. Leiden earned more than 98.5% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking9 out of 1,094
Percentile99.2%

In the industry of pharmaceutical preparations, Jeffrey M. Leiden's 2017 pay ranked 9th out of 1,094 executive pay records tracked by us.

Jeffrey M. Leiden earned more than 99.2% of executives in this industry.

Non-Equity Incentive Plan$3,463,200
Option Awards$3,700,877
Salary$1,300,000
Stock Awards$8,750,114
Other$13,110
Total$17,227,301

Leiden received $8.8M in stock awards, which accounts for 50.79% of total compensation.

Leiden also received $3.5M in non-equity incentive plan, $3.7M in option awards, $1.3M in salary and $13.1K in other compensation.

2016

In 2016, Jeffrey M. Leiden earned a total compensation of $17.4M as Chairman, President & CEO at Vertex Pharmaceuticals.

Ranking167 out of 13,853
Percentile98.8%

Jeffrey M. Leiden's 2016 compensation ranked 167th out of 13,853 executive pay records tracked by us this year.

Jeffrey M. Leiden earned more than 98.8% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking8 out of 1,120
Percentile99.3%

In the industry of pharmaceutical preparations, Jeffrey M. Leiden's 2016 pay ranked 8th out of 1,120 executive pay records tracked by us.

Jeffrey M. Leiden earned more than 99.3% of executives in this industry.

Non-Equity Incentive Plan$2,246,400
Option Awards$4,060,397
Salary$1,300,000
Stock Awards$9,800,076
Other$12,885
Total$17,419,758

Leiden received $9.8M in stock awards, which accounts for 56.26% of total compensation.

Leiden also received $2.2M in non-equity incentive plan, $4.1M in option awards, $1.3M in salary and $12.9K in other compensation.

2015

In 2015, Jeffrey M. Leiden earned a total compensation of $28.1M as Chairman, President & CEO at Vertex Pharmaceuticals.

Ranking43 out of 13,574
Percentile99.7%

Jeffrey M. Leiden's 2015 compensation ranked 43rd out of 13,574 executive pay records tracked by us this year.

Jeffrey M. Leiden earned more than 99.7% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking6 out of 1,144
Percentile99.5%

In the industry of pharmaceutical preparations, Jeffrey M. Leiden's 2015 pay ranked 6th out of 1,144 executive pay records tracked by us.

Jeffrey M. Leiden earned more than 99.5% of executives in this industry.

Non-Equity Incentive Plan$3,463,200
Option Awards$16,286,939
Salary$1,297,692
Stock Awards$7,038,885
Other$13,110
Total$28,099,826

Leiden received $16.3M in option awards, which accounts for 57.96% of total compensation.

Leiden also received $3.5M in non-equity incentive plan, $1.3M in salary, $7M in stock awards and $13.1K in other compensation.

2014

In 2014, Jeffrey M. Leiden earned a total compensation of $36.6M as Chairman, President & CEO at Vertex Pharmaceuticals.

Ranking34 out of 12,876
Percentile99.7%

Jeffrey M. Leiden's 2014 compensation ranked 34th out of 12,876 executive pay records tracked by us this year.

Jeffrey M. Leiden earned more than 99.7% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking3 out of 1,003
Percentile99.7%

In the industry of pharmaceutical preparations, Jeffrey M. Leiden's 2014 pay ranked 3rd out of 1,003 executive pay records tracked by us.

Jeffrey M. Leiden earned more than 99.7% of executives in this industry.

Non-Equity Incentive Plan$2,970,000
Option Awards$12,669,261
Salary$1,100,000
Stock Awards$19,883,350
Other$12,857
Total$36,635,468

Leiden received $19.9M in stock awards, which accounts for 54.27% of total compensation.

Leiden also received $3M in non-equity incentive plan, $12.7M in option awards, $1.1M in salary and $12.9K in other compensation.

2013

In 2013, Jeffrey M. Leiden earned a total compensation of $13.1M as Chairman, President & CEO at Vertex Pharmaceuticals.

Ranking229 out of 11,965
Percentile98.1%

Jeffrey M. Leiden's 2013 compensation ranked 229th out of 11,965 executive pay records tracked by us this year.

Jeffrey M. Leiden earned more than 98.1% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking11 out of 844
Percentile98.7%

In the industry of pharmaceutical preparations, Jeffrey M. Leiden's 2013 pay ranked 11th out of 844 executive pay records tracked by us.

Jeffrey M. Leiden earned more than 98.7% of executives in this industry.

Non-Equity Incentive Plan$2,772,000
Option Awards$7,529,374
Salary$1,038,462
Stock Awards$1,773,963
Other$12,675
Total$13,126,474

Leiden received $7.5M in option awards, which accounts for 57.36% of total compensation.

Leiden also received $2.8M in non-equity incentive plan, $1M in salary, $1.8M in stock awards and $12.7K in other compensation.

2012

In 2012, Jeffrey M. Leiden earned a total compensation of $5.7M as Chairman, President & CEO at Vertex Pharmaceuticals.

Ranking1,018 out of 10,949
Percentile90.7%

Jeffrey M. Leiden's 2012 compensation ranked 1,018th out of 10,949 executive pay records tracked by us this year.

Jeffrey M. Leiden earned more than 90.7% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking44 out of 644
Percentile93.2%

In the industry of pharmaceutical preparations, Jeffrey M. Leiden's 2012 pay ranked 44th out of 644 executive pay records tracked by us.

Jeffrey M. Leiden earned more than 93.2% of executives in this industry.

Non-Equity Incentive Plan$2,088,000
Option Awards$2,556,234
Salary$1,000,000
Other$12,450
Total$5,656,684

Leiden received $2.6M in option awards, which accounts for 45.19% of total compensation.

Leiden also received $2.1M in non-equity incentive plan, $1M in salary and $12.5K in other compensation.

2011

In 2011, Jeffrey M. Leiden earned a total compensation of $10.7M as Chairman, President & CEO at Vertex Pharmaceuticals.

Ranking314 out of 10,035
Percentile96.9%

Jeffrey M. Leiden's 2011 compensation ranked 314th out of 10,035 executive pay records tracked by us this year.

Jeffrey M. Leiden earned more than 96.9% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking11 out of 515
Percentile97.9%

In the industry of pharmaceutical preparations, Jeffrey M. Leiden's 2011 pay ranked 11th out of 515 executive pay records tracked by us.

Jeffrey M. Leiden earned more than 97.9% of executives in this industry.

Option Awards$7,077,542
Salary$50,000
Stock Awards$3,497,678
Other$92,441
Total$10,717,661

Leiden received $7.1M in option awards, which accounts for 66.04% of total compensation.

Leiden also received $50K in salary, $3.5M in stock awards and $92.4K in other compensation.

Abbott Laboratories

Former President and Chief Operating Officer, Pharmaceutical Products Group and Director

Annual data

2006

In 2006, Jeffrey M. Leiden earned a total compensation of $4.8M as Former President and Chief Operating Officer, Pharmaceutical Products Group and Director at Abbott Laboratories.

Ranking536 out of 5,364
Percentile90.0%

Jeffrey M. Leiden's 2006 compensation ranked 536th out of 5,364 executive pay records tracked by us this year.

Jeffrey M. Leiden earned more than 90.0% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking21 out of 296
Percentile92.9%

In the industry of pharmaceutical preparations, Jeffrey M. Leiden's 2006 pay ranked 21st out of 296 executive pay records tracked by us.

Jeffrey M. Leiden earned more than 92.9% of executives in this industry.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$241,792
Salary$225,083
Stock Awards$4,053,861
Other$244,055
Total$4,764,791

Leiden received $4.1M in stock awards, which accounts for 85.08% of total compensation.

Leiden also received $241.8K of change in pension value and nonqualified deferred compensation earnings, $225.1K in salary and $244.1K in other compensation.